Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare lung disease characterised by abnormal alveolar surfactant accumulation due to macrophage dysfunction. Whole lung lavage (WLL) is the cornerstone of first-line aPAP therapy, but effective rescue treatments have not yet been well established....

Descripción completa

Detalles Bibliográficos
Autores principales: Bird, Daniel, Evans, Jack, Pahoff, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943437/
https://www.ncbi.nlm.nih.gov/pubmed/35342706
http://dx.doi.org/10.1016/j.rmcr.2022.101637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943437/
https://www.ncbi.nlm.nih.gov/pubmed/35342706
http://dx.doi.org/10.1016/j.rmcr.2022.101637

Ejemplares similares